www.hivandhepatitis.com

Back HIV Prevention Pre-exposure (PrEP)

Pre-exposure Prophylaxis (PrEP)

PrEP using Tenofovir plus Emtricitabine May Offer Benefits even if HIV Infection Occurs

Details
Category: Pre-exposure Prophylaxis (PrEP)
Published on Tuesday, 07 October 2008 14:10
Written by HIVandHepatitis.com
  • Print

Animal studies of pre-exposure prophylaxis (PrEP) using tenofovir (Viread), with or without emtricitabine (Emtriva), have produced promising results, and large clinical trials in humans are currently underway. Prevention strategies using antiretroviral drugs are unlikely to be 100% effective, due to variations in efficacy, adherence, and other factors. But there is growing evidence that PrEP may have benefits even for individuals who become infected.

Read more:

Copyright © 2023 www.hivandhepatitis.com. All Rights Reserved. Designed by JoomlArt.com. Joomla! is Free Software released under the GNU General Public License.

Bread and Roses Web DesignWeb Design and Development by Bread and Roses Web Design